Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study.
Saved in:
| Title: | Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study. |
|---|---|
| Authors: | De Laurentiis M; Breast Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione Pascale, Napoli, Italy. m.delaurentiis@breastunit.org., Caputo R; Istituto Nazionale Tumori 'Fondazione Pascale', Napoli, Italy., Mazza M; Senologia Medica, Istituto Europeo di Oncologia, Milano, Italy., Mansutti M; Department of Oncology, Santa Maria della Misericordia hospital, Udine, Italy., Masetti R; Dipartimento di Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Gemelli IRCSS, Roma, Italy., Ballatore Z; Clinica Oncologica e Centro Regionale di Genetica Oncologica, AOU Ospedali Riuniti Ancona Università Politecnica delle Marche, Ancona, Italy., Torrisi R; Department of Medical Oncology, IRCCS-Humanitas Clinical and Research Hospital, Rozzano, Italy., Michelotti A; U.O. Oncologia Medica I, Azienda Ospedaliera Universitaria Pisana, Ospedale S. Chiara, Pisa, Italy., Zambelli A; Humanitas University, IRCCS Research Hospital, Rozzano, Italy., Ferro A; Medical Oncology, Ospedale Santa Chiara, Trento, Italy., Generali D; U.O.C. Multidisciplinare di Patologia Mammaria, Istituti Ospitalieri di Cremona, ASST di Cremona, Cremona, Italy., Vici P; UOSD Sperimentazioni di fase IV, IRCCS Regina Elena National Cancer Institute, Roma, Italy., Coltelli L; U.O.C. di Oncologia Medica, Presidio Ospedaliero Livorno, Livorno, Italy., Fabi A; Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Roma, Italy., Marchetti P; UOC Oncologia Medica, Azienda Ospedaliera St. Andrea, Rome, Italy., Ballestrero A; Dipartimento di Medicina Interna DIMI, Ospedale Policlinico San Martino IRCCS, Genova, Italy., Spazzapan S; S.O.C. Oncologia Medica e Prevenzione Oncologica, Centro di Riferimento Oncologico IRCCS, Aviano, Italy., Frassoldati A; U.O.C. Oncologia Clinica, Azienda Ospedaliero, Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara, Italy., Sarobba MG; UOC Oncologia, Presidio Ospedaliero S. Francesco, ASL Nuoro, Nuoro, Italy., Grasso D; Oncology, Novartis Farma SpA, Origgio, Italy., Zamagni C; Addarii Medical Oncology Unit IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy. |
| Source: | Targeted oncology [Target Oncol] 2022 Nov; Vol. 17 (6), pp. 615-625. Date of Electronic Publication: 2022 Sep 24. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36152144 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22De+Laurentiis+M%22">De Laurentiis M</searchLink>; Breast Oncology, Istituto Nazionale Tumori, IRCCS, Fondazione Pascale, Napoli, Italy. m.delaurentiis@breastunit.org.<br /><searchLink fieldCode="AU" term="%22Caputo+R%22">Caputo R</searchLink>; Istituto Nazionale Tumori 'Fondazione Pascale', Napoli, Italy.<br /><searchLink fieldCode="AU" term="%22Mazza+M%22">Mazza M</searchLink>; Senologia Medica, Istituto Europeo di Oncologia, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Mansutti+M%22">Mansutti M</searchLink>; Department of Oncology, Santa Maria della Misericordia hospital, Udine, Italy.<br /><searchLink fieldCode="AU" term="%22Masetti+R%22">Masetti R</searchLink>; Dipartimento di Scienze della Salute della Donna e del Bambino e di Sanità Pubblica, Fondazione Policlinico Gemelli IRCSS, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Ballatore+Z%22">Ballatore Z</searchLink>; Clinica Oncologica e Centro Regionale di Genetica Oncologica, AOU Ospedali Riuniti Ancona Università Politecnica delle Marche, Ancona, Italy.<br /><searchLink fieldCode="AU" term="%22Torrisi+R%22">Torrisi R</searchLink>; Department of Medical Oncology, IRCCS-Humanitas Clinical and Research Hospital, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Michelotti+A%22">Michelotti A</searchLink>; U.O. Oncologia Medica I, Azienda Ospedaliera Universitaria Pisana, Ospedale S. Chiara, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Zambelli+A%22">Zambelli A</searchLink>; Humanitas University, IRCCS Research Hospital, Rozzano, Italy.<br /><searchLink fieldCode="AU" term="%22Ferro+A%22">Ferro A</searchLink>; Medical Oncology, Ospedale Santa Chiara, Trento, Italy.<br /><searchLink fieldCode="AU" term="%22Generali+D%22">Generali D</searchLink>; U.O.C. Multidisciplinare di Patologia Mammaria, Istituti Ospitalieri di Cremona, ASST di Cremona, Cremona, Italy.<br /><searchLink fieldCode="AU" term="%22Vici+P%22">Vici P</searchLink>; UOSD Sperimentazioni di fase IV, IRCCS Regina Elena National Cancer Institute, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Coltelli+L%22">Coltelli L</searchLink>; U.O.C. di Oncologia Medica, Presidio Ospedaliero Livorno, Livorno, Italy.<br /><searchLink fieldCode="AU" term="%22Fabi+A%22">Fabi A</searchLink>; Division of Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Roma, Italy.<br /><searchLink fieldCode="AU" term="%22Marchetti+P%22">Marchetti P</searchLink>; UOC Oncologia Medica, Azienda Ospedaliera St. Andrea, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Ballestrero+A%22">Ballestrero A</searchLink>; Dipartimento di Medicina Interna DIMI, Ospedale Policlinico San Martino IRCCS, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Spazzapan+S%22">Spazzapan S</searchLink>; S.O.C. Oncologia Medica e Prevenzione Oncologica, Centro di Riferimento Oncologico IRCCS, Aviano, Italy.<br /><searchLink fieldCode="AU" term="%22Frassoldati+A%22">Frassoldati A</searchLink>; U.O.C. Oncologia Clinica, Azienda Ospedaliero, Universitaria di Ferrara - Arcispedale Sant'Anna, Ferrara, Italy.<br /><searchLink fieldCode="AU" term="%22Sarobba+MG%22">Sarobba MG</searchLink>; UOC Oncologia, Presidio Ospedaliero S. Francesco, ASL Nuoro, Nuoro, Italy.<br /><searchLink fieldCode="AU" term="%22Grasso+D%22">Grasso D</searchLink>; Oncology, Novartis Farma SpA, Origgio, Italy.<br /><searchLink fieldCode="AU" term="%22Zamagni+C%22">Zamagni C</searchLink>; Addarii Medical Oncology Unit IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2022 Nov; Vol. 17 (6), pp. 615-625. <i>Date of Electronic Publication: </i>2022 Sep 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36152144 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11523-022-00913-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 615 Titles: – TitleFull: Safety and Efficacy of Ribociclib in Combination with Letrozole in Patients with HR+, HER2- Advanced Breast Cancer: Results from the Italian Subpopulation of Phase 3b CompLEEment-1 Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: De Laurentiis M – PersonEntity: Name: NameFull: Caputo R – PersonEntity: Name: NameFull: Mazza M – PersonEntity: Name: NameFull: Mansutti M – PersonEntity: Name: NameFull: Masetti R – PersonEntity: Name: NameFull: Ballatore Z – PersonEntity: Name: NameFull: Torrisi R – PersonEntity: Name: NameFull: Michelotti A – PersonEntity: Name: NameFull: Zambelli A – PersonEntity: Name: NameFull: Ferro A – PersonEntity: Name: NameFull: Generali D – PersonEntity: Name: NameFull: Vici P – PersonEntity: Name: NameFull: Coltelli L – PersonEntity: Name: NameFull: Fabi A – PersonEntity: Name: NameFull: Marchetti P – PersonEntity: Name: NameFull: Ballestrero A – PersonEntity: Name: NameFull: Spazzapan S – PersonEntity: Name: NameFull: Frassoldati A – PersonEntity: Name: NameFull: Sarobba MG – PersonEntity: Name: NameFull: Grasso D – PersonEntity: Name: NameFull: Zamagni C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2022 Nov Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1776-260X Numbering: – Type: volume Value: 17 – Type: issue Value: 6 Titles: – TitleFull: Targeted oncology Type: main |
| ResultId | 1 |
